Follow-up study to evaluate the impact of atrial fibrillation on mortality and the occurrence of complications in patients with transcatheter aortic valve implantatio
- Conditions
- Z95.4Presence of other heart-valve replacement
- Registration Number
- DRKS00011798
- Lead Sponsor
- niversitätsklinik für Kardiologie und Angiologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 257
Inclusion Criteria
Patients with successful TAVI implantation.
Data from patients treated retrospectively from 2010-2017 are evaluated.
Exclusion Criteria
Not successful TAVI implantation or conversion to heart surgery.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complications of the blood, cerebrovascular events, vascular complications and mortality are retrospectively recorded and evaluated using the VARC criteria.<br><br>Events are collected before implantation and during the course of the course after 30 days, 3, 6, 9 and 12 months.
- Secondary Outcome Measures
Name Time Method